LFCR · TickerCove

LFCRLifecore Biomedical, Inc.Healthcare · Drug Manufacturers - Specialty & Genericas of 2026-09-16

Horizon

Issued 2026-09-16 at $4.16 · now $4.16 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, LFCR has typically landed between $3.20 and $5.28 — a range of −23.0% to +27.0% from the issuance price $4.16.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

5,001 overlapping 1 month windows · 2006-09-26 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($4.16) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$4.16 · 10% of range

$3.66 low$8.82 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

−1.3%

typical move · IQR 21.3%

−23.0%worst (p90)+27.0%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where LFCR has typically landed a month from the 2026-09-16 close of $4.16 — the range is history, not a prediction.

now $4.16 (+0.0%)
typical $4.11 (-1.3%)
middle 50% $3.66–$4.55
90% range $3.2–$5.28

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 5,001 windows spanning 2006-09-26 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2026-02-26	−50.3%	−50.3%	+0.0%
2023-02-17	−49.1%	−49.1%	+0.2%
2026-03-02	−48.5%	−49.4%	+0.0%
3 best
2023-05-12	+104.0%	−0.5%	+104.0%
2023-05-15	+100.9%	+0.0%	+104.9%
2023-04-26	+97.9%	+0.0%	+98.1%

5,001 overlapping windows · 2006-09-26 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

50%

−1.3%

n=20

Feb

40%

−0.9%

n=20

Mar

55%

−2.5%

n=20

Apr

55%

+4.7%

n=20

May

65%

+5.0%

n=20

Jun

55%

+0.4%

n=20

Jul

45%

+2.2%

n=20

Aug

50%

−0.3%

n=20

Sep

35%

−1.5%

n=20

Oct

50%

+1.3%

n=20

Nov

55%

+0.3%

n=20

Dec

45%

−1.2%

n=20

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2025-05-28	English Aron R.	director	Sale	150,419 @ $7.12	$1.1M	−36.3% of holding	+13.8%	−1.0%	264,180	Form 4 · filed same day
2025-05-27	English Aron R.	director	Sale	1,139,504 @ $6.50	$7.4M	−73.3% of holding	+13.8%	−6.5%	414,599	Form 4 · filed 1 day after the trade
2025-05-23	English Aron R.	director	Sale	96,137 @ $6.75	$649K	−5.8% of holding	+19.0%	−0.8%	1,554,103	Form 4 · filed 5 days after the trade
2025-05-13	English Aron R.	director	Sale	12,334 @ $7.00	$86K	−0.7% of holding	−4.6%	−5.7%	1,650,240	Form 4 · filed 3 days after the trade
2025-05-12	English Aron R.	director	Sale	45,698 @ $7.03	$321K	−2.7% of holding	−6.3%	−13.1%	1,662,574	Form 4 · filed same day
2025-05-09	English Aron R.	director	Sale	700 @ $7.00	$5K	−0.0% of holding	−8.4%	−21.3%	1,708,272	Form 4 · filed 3 days after the trade
2025-05-08	English Aron R.	director	Sale	5,098 @ $7.00	$36K	−0.3% of holding	−7.7%	−23.2%	1,708,972	Form 4 · filed 4 days after the trade
2025-05-07	English Aron R.	director	Sale	15,847 @ $7.01	$111K	−0.9% of holding	−8.9%	−24.7%	1,714,070	Form 4 · filed same day
2025-05-06	English Aron R.	director	Sale	701 @ $7.05	$5K	−0.0% of holding	−9.0%	−24.0%	1,729,917	Form 4 · filed 1 day after the trade
2025-05-05	English Aron R.	director	Sale	24,543 @ $7.08	$174K	−1.4% of holding	−7.7%	−20.7%	1,730,618	Form 4 · filed 2 days after the trade
2025-01-08	Josephs Paul	director	Purchase	17,000 @ $5.74	$98K	+3.1% of holding	−1.4%	+34.2%	559,717	Form 4 · filed same day

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

75 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-06-04	Kiper Christopher S	director	Award / grant	25,907	103,482	Form 4
2026-06-04	Kiper Christopher S	director	Award / grant	25,907	103,482	Form 4
2026-06-04	Kiper Christopher S	director	Award / grant	25,907	103,482	Form 4
2026-06-04	Kiper Christopher S	director	Award / grant	25,907	103,482	Form 4
2026-06-04	Kiper Christopher S	director	Award / grant	25,907	103,482	Form 4
2026-06-04	HOUDE LOVAS KATRINA	director	Award / grant	25,907	135,319	Form 4
2026-06-04	Kiper Christopher S	director	Award / grant	25,907	103,482	Form 4
2026-06-04	Kiper Christopher S	director	Award / grant	25,907	103,482	Form 4
2026-06-04	Schechter Joshua	director	Award / grant	25,907	133,080	Form 4
2026-06-04	Kiper Christopher S	director	Award / grant	25,907	103,482	Form 4
2026-06-04	HOUDE LOVAS KATRINA	director	Award / grant	25,907	135,319	Form 4
2026-06-04	Antunes Humberto Calheiros	director	Award / grant	25,907	72,967	Form 4
2026-06-04	Johnson Paul Harold	director	Award / grant	25,907	69,967	Form 4
2026-06-04	Aryeh Jason	director	Award / grant	25,907	69,967	Form 4
2026-06-04	Korenberg Matthew E	director	Award / grant	25,907	69,967	Form 4
2026-06-04	OBUS NELSON	director	Award / grant	25,907	164,100	Form 4
2026-06-04	Aryeh Jason	director	Award / grant	25,907	69,967	Form 4
2026-06-04	Korenberg Matthew E	director	Award / grant	25,907	69,967	Form 4
2026-06-04	Antunes Humberto Calheiros	director	Award / grant	25,907	72,967	Form 4
2026-06-04	Johnson Paul Harold	director	Award / grant	25,907	69,967	Form 4
2026-06-04	OBUS NELSON	director	Award / grant	25,907	164,100	Form 4
2026-06-04	Schechter Joshua	director	Award / grant	25,907	133,080	Form 4
2026-05-20	Josephs Paul	director	Withheld for tax	40,413	592,915	Form 4
2026-04-14	Salus Thomas D.	officer	Withheld for tax	24,645	246,333	Form 4
2026-03-02	Salus Thomas D.	officer	Award / grant	30,000	270,978	Form 4
2026-03-02	Salus Thomas D.	officer	Award / grant	30,000	270,978	Form 4
2025-09-03	Lake Ryan David	officer	Withheld for tax	22,932	336,691	Form 4
2025-07-15	Kiper Christopher S	director	Award / grant	19,506	77,575	Form 4
2025-07-15	Kiper Christopher S	director	Award / grant	19,506	77,575	Form 4
2025-07-15	Kiper Christopher S	director	Award / grant	19,506	77,575	Form 4
2025-07-15	Kiper Christopher S	director	Award / grant	19,506	77,575	Form 4
2025-07-15	Schechter Joshua	director	Award / grant	19,506	107,173	Form 4
2025-07-15	Antunes Humberto Calheiros	director	Award / grant	19,506	47,060	Form 4
2025-07-15	Korenberg Matthew E	director	Award / grant	19,506	44,060	Form 4
2025-07-15	Korenberg Matthew E	director	Award / grant	19,506	44,060	Form 4
2025-07-15	Kiper Christopher S	director	Award / grant	19,506	77,575	Form 4
2025-07-15	HOUDE LOVAS KATRINA	director	Award / grant	19,506	109,412	Form 4
2025-07-15	Aryeh Jason	director	Award / grant	19,506	44,060	Form 4
2025-07-15	Johnson Paul Harold	director	Award / grant	19,506	44,060	Form 4
2025-07-15	Antunes Humberto Calheiros	director	Award / grant	19,506	47,060	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i